ATE466015T1 - Verfahren zur herstellung von phenserin und dessen analogon - Google Patents

Verfahren zur herstellung von phenserin und dessen analogon

Info

Publication number
ATE466015T1
ATE466015T1 AT02790077T AT02790077T ATE466015T1 AT E466015 T1 ATE466015 T1 AT E466015T1 AT 02790077 T AT02790077 T AT 02790077T AT 02790077 T AT02790077 T AT 02790077T AT E466015 T1 ATE466015 T1 AT E466015T1
Authority
AT
Austria
Prior art keywords
phenserine
analogue
producing
compounds
isocyanate
Prior art date
Application number
AT02790077T
Other languages
English (en)
Inventor
Joerg Bruening
Original Assignee
Axonyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axonyx Inc filed Critical Axonyx Inc
Application granted granted Critical
Publication of ATE466015T1 publication Critical patent/ATE466015T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT02790077T 2002-01-09 2002-12-11 Verfahren zur herstellung von phenserin und dessen analogon ATE466015T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/042,586 US6495700B1 (en) 2002-01-09 2002-01-09 Process for producing phenserine and its analog
PCT/US2002/039537 WO2003059909A1 (en) 2002-01-09 2002-12-11 A process for producing phenserine and its analog

Publications (1)

Publication Number Publication Date
ATE466015T1 true ATE466015T1 (de) 2010-05-15

Family

ID=21922704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02790077T ATE466015T1 (de) 2002-01-09 2002-12-11 Verfahren zur herstellung von phenserin und dessen analogon

Country Status (15)

Country Link
US (1) US6495700B1 (de)
EP (1) EP1463729B1 (de)
JP (1) JP2005514459A (de)
KR (2) KR100712003B1 (de)
CN (1) CN1301995C (de)
AT (1) ATE466015T1 (de)
AU (1) AU2002353102B2 (de)
BR (1) BRPI0215492A2 (de)
CA (1) CA2470560C (de)
DE (1) DE60236207D1 (de)
HR (1) HRP20040606A2 (de)
HU (1) HUP0500747A3 (de)
IL (1) IL162827A0 (de)
PL (1) PL374240A1 (de)
WO (1) WO2003059909A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897639B2 (en) 2003-10-21 2011-03-01 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
US20070167509A1 (en) * 2005-06-14 2007-07-19 Joseph Araujo Use of phenserine and analogs to treat behavioral problems and improve trainability
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
EP2533645B1 (de) 2010-02-09 2016-07-27 The Johns Hopkins University Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen
US20120225922A1 (en) 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
US20130096316A1 (en) * 2011-10-14 2013-04-18 Qr Pharma, Inc. Novel Method for Preparation of Bisnorcymerine and Salts Thereof
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
EP2968220B1 (de) 2013-03-15 2021-05-05 Agenebio, Inc. Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen
EP2968237A4 (de) 2013-03-15 2016-08-31 Univ Johns Hopkins Verfahren und zusammensetzungen zur verbesserung der kognitiven funktion
MX384391B (es) 2015-05-22 2025-03-14 Agenebio Inc Composiciones farmacéuticas de levetiracetam de liberación extendida.
EP3334425B1 (de) 2015-08-14 2020-12-16 QR Pharma Verfahren zur behandlung oder prävention von akuten hirn- oder nervenläsionen
CA3083015A1 (en) 2017-05-24 2018-11-28 Qr Pharma, Inc. Prevention or treatment of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
US5306825A (en) 1984-03-01 1994-04-26 Consiglio Nazionale Delle Ricerche Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4791107A (en) 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US5187165A (en) 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US5260452A (en) 1989-11-03 1993-11-09 Hoechst-Roussel Pharmaceuticals Inc. 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof
US5177101A (en) 1989-11-30 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5077289A (en) 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5705657A (en) 1991-02-14 1998-01-06 Labochim Laboratorio Chimico Internazionale S.P.A. Isocyanate process for the preparation of 1,3A,8-trimethyl-1,2,3,3A, 8, 8A-hexahydro-pyrrole 2,3-B! indol-5 (3AS, 8AR) -hepthylcarbamate
EP0499959A1 (de) 1991-02-18 1992-08-26 Bromine Compounds Ltd. Verfahren zur Herstellung von substituierten Haleimiden
AU674130B2 (en) 1991-09-26 1996-12-12 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Substituted phenserines and phenylcarbamates of (-)- eseroline, (-)-N1-noreseroline, and (-)-N1- benzylnoreseroline; as specific inhibitors of acetylcholinesterase
US5206260A (en) 1991-11-07 1993-04-27 Merck & Co., Inc. Hexahydropyrrolo[2,3-b]indole derivatives
US5302721A (en) 1992-07-21 1994-04-12 Hoechst-Roussel Pharmaceuticals Incorporated Method of preparation of physostigmine carbamate derivatives from eseretholes
PH30885A (en) * 1992-07-21 1997-12-23 Hoechst Roussel Pharma Preparation of physostigmie carbamate derivatives from physostigmine.
US5409948A (en) 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5665880A (en) 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers

Also Published As

Publication number Publication date
KR20040072711A (ko) 2004-08-18
HUP0500747A3 (en) 2009-05-28
DE60236207D1 (de) 2010-06-10
WO2003059909A1 (en) 2003-07-24
US6495700B1 (en) 2002-12-17
AU2002353102B2 (en) 2007-05-24
CN1301995C (zh) 2007-02-28
HRP20040606A2 (en) 2004-12-31
AU2002353102A1 (en) 2003-07-30
EP1463729A4 (de) 2005-06-29
HUP0500747A2 (hu) 2005-11-28
CA2470560A1 (en) 2003-07-24
KR100712003B1 (ko) 2007-05-02
CN1612880A (zh) 2005-05-04
JP2005514459A (ja) 2005-05-19
IL162827A0 (en) 2005-11-20
BRPI0215492A2 (pt) 2016-07-05
HK1075659A1 (en) 2005-12-23
EP1463729B1 (de) 2010-04-28
EP1463729A1 (de) 2004-10-06
PL374240A1 (en) 2005-10-03
CA2470560C (en) 2007-05-15
KR20060097772A (ko) 2006-09-15

Similar Documents

Publication Publication Date Title
ATE466015T1 (de) Verfahren zur herstellung von phenserin und dessen analogon
ATE534629T1 (de) Verfahren und verbindungen zur herstellung von cc-1065-analoga
ATE501126T1 (de) Verfahren zur herstellung von rosuvastatin
ATE489365T1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
DE60328492D1 (de) Verfahren zur erzeugung von nanoteilchen
ATE381727T1 (de) Verfahren zur multiphotonen-photosensibilisierung
DE60317651D1 (de) Verfahren zur herstellung von hochmolekularen verbindungen für photoresists
ATE360653T1 (de) Verfahren zur herstellung von polyisobutenen
DE502004005626D1 (de) Verfahren zur herstellung von organoacylphosphiten
ATE456569T1 (de) Verfahren zur herstellung von 6-alkyliden- penemderivaten
ATE431339T1 (de) Verfahren zur herstellung von n-amino- substituierten heterocyclischen verbindungen
ATE470657T1 (de) Verfahren zur herstellung von isocyanaten
ATE322495T1 (de) Verfahren zur herstellung von kristallinem n- formimidoylthienamycin-monohydrat (imipenem- monohydrat)
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
ATE528280T1 (de) Verfahren zur herstellung von triethanolamin
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
ATE370950T1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
ATE375355T1 (de) Verfahren zur herstellung von cefpodoxim-proxetil
DE60331302D1 (de) Verfahren zur herstellung von dichtungen
ATE469141T1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE297404T1 (de) Verbessertes verfahren zur herstellung von bisphosphiten